<DOC>
	<DOCNO>NCT01285973</DOCNO>
	<brief_summary>The aim prospective study assess utility treatment leg ulcer use skin substitute , Integra® , assess quality wound skin heal transcutaneous oxygen pressure distal region wound . This multi-centre study 60 patient low limb ulcer .</brief_summary>
	<brief_title>Evaluation Integra® Artificial Dermis Treatment Leg Ulcers</brief_title>
	<detailed_description />
	<criteria>patient low limb ulcer , regardless origin ( arterial , venous mixed , diabetic foot ulcer ) present 6 month large size ( &gt; 10 cm² ) patient surgeon recommend Integra® matrix implant ( even patient take part study ) dermoepidermal graft obtain richly vascularise neodermis . eligible skin flap surgery , patient patient 's representative agree sign information letter investigation require research . circumferential wound , wound infection immunosuppressed patient , know allergy bovine collagen , bovine glycosaminoglycans silicone , patient legal guardianship , pregnant woman patient whose health would compromise followup least 18 month , patient whose mental health would compromise completion selfevaluation questionnaire . wound locate area visible patient ( selfassessment would possible ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>